Back

Residual cholesterol and inflammatory risk in statin-treated patients undergoing percutaneous coronary intervention: challenges with the proportional hazards assumption and coping strategies

European Heart Journal

3 June 2026
Organised by: Logo
Read full article
ESC Journals CORONARY ARTERY DISEASE, ACUTE CORONARY SYNDROMES, ACUTE CARDIAC CARE Acute Coronary Syndromes

Contributors

Zichun Huang
Zichun Huang

Author

You may be interested in
thumbnail
Congress Presentation
Inflammation and cholesterol associated residual cardiovascular risk and its dependence on chronic kidney disease in statin treated patients with coronary artery disease
30 August 2024
thumbnail
Congress Presentation
Risk factors control, remnant cholesterol, recurrent events and risk in patients with coronary heart disease. Our experiences
4 April 2025
thumbnail
Webinar
Lipid management pathways and ESC Guidelines
10 January 2023
thumbnail
Congress Presentation
Prognostic impact of elevated baseline CRP levels in primary PCI-treated patients with residual cholesterol risk
28 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources